CAS 1162-56-7|6-Dehydroprogesterone
Introduction：Basic information about CAS 1162-56-7|6-Dehydroprogesterone, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | 6-Dehydroprogesterone | ||
|---|---|---|---|
| CAS Number | 1162-56-7 | Molecular Weight | 312.446 |
| Density | 1.1±0.1 g/cm3 | Boiling Point | 462.8±45.0 °C at 760 mmHg |
| Molecular Formula | C21H28O2 | Melting Point | 146 °C |
| MSDS | / | Flash Point | 172.2±25.7 °C |
Names
| Name | Pregna-4,6-diene-3,20-dione |
|---|---|
| Synonym | More Synonyms |
Chemical & Physical Properties
| Density | 1.1±0.1 g/cm3 |
|---|---|
| Boiling Point | 462.8±45.0 °C at 760 mmHg |
| Melting Point | 146 °C |
| Molecular Formula | C21H28O2 |
| Molecular Weight | 312.446 |
| Flash Point | 172.2±25.7 °C |
| Exact Mass | 312.208923 |
| PSA | 34.14000 |
| LogP | 3.58 |
| Vapour Pressure | 0.0±1.1 mmHg at 25°C |
| Index of Refraction | 1.557 |
| InChIKey | JGMOKGBVKVMRFX-LEKSSAKUSA-N |
| SMILES | CC(=O)C1CCC2C3C=CC4=CC(=O)CCC4(C)C3CCC12C |
Safety Information
| HS Code | 2937190090 |
|---|
Customs
| HS Code | 2937190090 |
|---|
Articles25
More Articles| Coagulation and fibrynolitic parameters in women and the effects of hormone therapy; comparison of transdermal and oral administration. Gynecol. Endocrinol. 29(2) , 165-8, (2013) It is established that hormone therapy (HT) is related with significant increased prothrombotic risk factor. The aim of our study was to assess the effects of oral hormone therapy (o-HT) and transderm... | |
| Oral estradiol and dydrogesterone combination therapy in postmenopausal women: review of efficacy and safety. Maturitas 76(1) , 10-21, (2013) HRT is known to be effective for the relief of menopausal symptoms and prevention of osteoporosis. HRT should be tailored to the woman, enhancing the beneficial effects of the treatment while minimizi... | |
| Hormone replacement therapy regimens in chemotherapy-induced premature ovarian failure and the subsequent correction of hormone levels. Neuro Endocrinol. Lett. 33(7) , 697-702, (2012) Premature ovarian failure (POF) is a consequence of gonadotoxic chemoradiotherapy given in antyneoplasia treatment. In young women it will correlate with menopausal symptoms which tend to appear due t... |
Synonyms
| 4,6-pregnadiene-3,20-dione |
| pregna-4,6-diene-2,30-dione |
| Dehydroprogesterone |
| MFCD00199858 |
| 4,6-PREGNADIEN-3,20-DIONE |
| CIS-DYDROGESTERONE |
| Dydrogesterone impurity B |
| 6-Dehydroprogesterone |
| Pregna-4,6-diene-3,20-dione |
| 6,7-Didehydroprogesterone |
